EXAS
Price
$44.08
Change
-$0.07 (-0.16%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
12.78B
7 days until earnings call
FNA
Price
$13.09
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
998.19M
19 days until earnings call
Ad is loading...

EXAS vs FNA

Header iconEXAS vs FNA Comparison
Open Charts EXAS vs FNABanner chart's image
Exact Sciences
Price$44.08
Change-$0.07 (-0.16%)
Volume$20.55K
Capitalization12.78B
Paragon 28
Price$13.09
Change-$0.00 (-0.00%)
Volume$19.38M
Capitalization998.19M
EXAS vs FNA Comparison Chart
Loading...
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EXAS vs. FNA commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXAS is a Hold and FNA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (EXAS: $44.09 vs. FNA: $13.09)
Brand notoriety: EXAS: Notable vs. FNA: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EXAS: 66% vs. FNA: 544%
Market capitalization -- EXAS: $12.78B vs. FNA: $998.19M
EXAS [@Medical Specialties] is valued at $12.78B. FNA’s [@Medical Specialties] market capitalization is $998.19M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXAS’s FA Score shows that 0 FA rating(s) are green whileFNA’s FA Score has 0 green FA rating(s).

  • EXAS’s FA Score: 0 green, 5 red.
  • FNA’s FA Score: 0 green, 5 red.
According to our system of comparison, FNA is a better buy in the long-term than EXAS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXAS’s TA Score shows that 4 TA indicator(s) are bullish while FNA’s TA Score has 5 bullish TA indicator(s).

  • EXAS’s TA Score: 4 bullish, 3 bearish.
  • FNA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, FNA is a better buy in the short-term than EXAS.

Price Growth

EXAS (@Medical Specialties) experienced а +4.33% price change this week, while FNA (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was -3.85%.

Reported Earning Dates

EXAS is expected to report earnings on Aug 05, 2025.

FNA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXAS($12.8B) has a higher market cap than FNA($998M). FNA YTD gains are higher at: 26.718 vs. EXAS (-21.427). EXAS has higher annual earnings (EBITDA): 29.3M vs. FNA (-26.92M). EXAS has more cash in the bank: 778M vs. FNA (75.6M). FNA has less debt than EXAS: FNA (110M) vs EXAS (2.56B). EXAS has higher revenues than FNA: EXAS (2.5B) vs FNA (216M).
EXASFNAEXAS / FNA
Capitalization12.8B998M1,283%
EBITDA29.3M-26.92M-109%
Gain YTD-21.42726.718-80%
P/E RatioN/A370.37-
Revenue2.5B216M1,157%
Total Cash778M75.6M1,029%
Total Debt2.56B110M2,323%
FUNDAMENTALS RATINGS
EXAS: Fundamental Ratings
EXAS
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EXASFNA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 7 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 7 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 7 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 7 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 24 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 17 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 7 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIVCX17.400.32
+1.87%
American Funds International Vntg 529-E
FGROX20.56N/A
N/A
Emerald Growth Institutional
TILIX55.55N/A
N/A
Nuveen Large Cap Gr Idx R6
ALMZX21.50N/A
N/A
Alger MidCap Growth Institutional Z-2
READX11.80N/A
N/A
Lazard Emerging Markets Eq Advtg R6

EXAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXAS has been loosely correlated with QGEN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if EXAS jumps, then QGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXAS
1D Price
Change %
EXAS100%
+2.44%
QGEN - EXAS
55%
Loosely correlated
+4.59%
RGEN - EXAS
55%
Loosely correlated
+5.54%
QDEL - EXAS
34%
Loosely correlated
-0.41%
FNA - EXAS
32%
Poorly correlated
N/A
ILMN - EXAS
32%
Poorly correlated
+3.26%
More

FNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, FNA has been loosely correlated with NPCE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FNA jumps, then NPCE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FNA
1D Price
Change %
FNA100%
N/A
NPCE - FNA
44%
Loosely correlated
+3.80%
TMCI - FNA
35%
Loosely correlated
-2.80%
KIDS - FNA
35%
Loosely correlated
+1.17%
GMED - FNA
35%
Loosely correlated
+0.97%
EXAS - FNA
32%
Poorly correlated
+2.44%
More